Literature DB >> 7057659

Effect of Bacopa monniera Linn. (brahmi) extract on avoidance responses in rat.

H K Singh, B N Dhawan.   

Abstract

Brahmi (Bacopa monniera Linn.) is a reputed nerve tonic in Ayurvedic literature. Hence its effects on the learning performance of rats have been studied in different conditioning schedules by administering an aqueous suspension of an alcoholic extract (40 mg/kg, p.o.) for three or more days. The first schedule induced a labile behaviour using a shock-motivated brightness-discrimination reaction. The brahmi-treated group showed better acquisition, improved retention and delayed extinction (p is less than 0.01-0.05). Similarly, in an active conditioned flight reaction, the drug-treated animals showed a shorter reaction time than the controls (p less than 0.01). Also in the continuous avoidance response the drug-treated group performed better than the controls (p less than 0.01-0.05). Our findings are in conformity with the Ayurvedic claims and indicate that Bacopa monniera can improve the performance of rats in various learning situations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7057659     DOI: 10.1016/0378-8741(82)90044-7

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  34 in total

1.  Protective effect of Bacopa monniera on methyl mercury-induced oxidative stress in cerebellum of rats.

Authors:  Thangarajan Sumathi; Chandrasekar Shobana; Johnson Christinal; Chandran Anusha
Journal:  Cell Mol Neurobiol       Date:  2012-02-26       Impact factor: 5.046

2.  Attenuation of 1-(m-chlorophenyl)-biguanide induced hippocampus-dependent memory impairment by a standardised extract of Bacopa monniera (BESEB CDRI-08).

Authors:  Koilmani Emmanuvel Rajan; Hemant K Singh; Arunagiri Parkavi; Prisila Dulcy Charles
Journal:  Neurochem Res       Date:  2011-07-07       Impact factor: 3.996

Review 3.  Neuroprotection with Bacopa monnieri-A review of experimental evidence.

Authors:  Vijayanna Tirumalapura Shalini; Sajjanar Jambappa Neelakanta; Jaideep Sitaram Sriranjini
Journal:  Mol Biol Rep       Date:  2021-03-06       Impact factor: 2.316

4.  HPLC analysis and standardization of Brahmi vati - An Ayurvedic poly-herbal formulation.

Authors:  Amrita Mishra; Arun K Mishra; Om Prakash Tiwari; Shivesh Jha
Journal:  J Young Pharm       Date:  2013-09-30

5.  Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults.

Authors:  Vidya Sathyanarayanan; Tinku Thomas; Suzanne J L Einöther; Rajendra Dobriyal; M K Joshi; Srinivasan Krishnamachari
Journal:  Psychopharmacology (Berl)       Date:  2013-01-26       Impact factor: 4.530

Review 6.  Neuropharmacological review of the nootropic herb Bacopa monnieri.

Authors:  Sebastian Aguiar; Thomas Borowski
Journal:  Rejuvenation Res       Date:  2013-08       Impact factor: 4.663

7.  Bacopa monniera ameliorates cognitive impairment and neurodegeneration induced by intracerebroventricular-streptozotocin in rat: behavioral, biochemical, immunohistochemical and histopathological evidences.

Authors:  M Badruzzaman Khan; Muzamil Ahmad; Saif Ahmad; Tauheed Ishrat; Kumar Vaibhav; Gulrana Khuwaja; Fakhrul Islam
Journal:  Metab Brain Dis       Date:  2014-07-19       Impact factor: 3.584

8.  Scopolamine induced amnesia is reversed by Bacopa monniera through participation of kinase-CREB pathway.

Authors:  Manish Kumar Saraf; Akshay Anand; Sudesh Prabhakar
Journal:  Neurochem Res       Date:  2009-09-16       Impact factor: 3.996

9.  Neuroprotective role of Bacopa monnieri extract in epilepsy and effect of glucose supplementation during hypoxia: glutamate receptor gene expression.

Authors:  C S Paulose; Finla Chathu; S Reas Khan; Amee Krishnakumar
Journal:  Neurochem Res       Date:  2007-10-18       Impact factor: 3.996

10.  Enhancement of Amygdaloid Neuronal Dendritic Arborization by Fresh Leaf Juice of Centella asiatica (Linn) During Growth Spurt Period in Rats.

Authors:  K G Mohandas Rao; S Muddanna Rao; S Gurumadhva Rao
Journal:  Evid Based Complement Alternat Med       Date:  2007-08-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.